Literature DB >> 8828625

Utilisation of amino acid mixtures in adolescents with phenylketonuria.

E Mönch1, M E Herrmann, H Brösicke, A Schöffer, M Keller.   

Abstract

The nutritional regimen of patients with phenylketonuria (PKU) comprises a diet of natural proteins and phenylalanine (Phe)-free amino acid (AA) mixture. The main daily protein requirement is covered by a Phe-free AA mixture. In an adult with PKU, the consumption of the daily AA requirement in one single dose at breakfast caused nausea and vomiting. Therefore, four studies were designed to investigate the adverse and metabolic effects resulting from large intakes of AA mixtures used in the treatment of PKU patients with respect to the following: (1) biochemical effects following consumption of one single dose of Phe-free AA mixture in healthy persons; (2) transient metabolic changes caused by different individual regimens of AA intake in healthy persons and in one PKU patient; (3) nitrogen excretion in PKU patients taking the AA mixture in two or three portions; and (4) catabolic metabolism of AA in a PKU patient. In healthy subjects following the ingestion of the AA mixture in one bolus there was an increase in the blood levels of the given AA and also an increase in blood insulin concentration and a decrease in blood glucose concentration. These changes were less marked when the AA mixture was divided into three portions per day. In contrast, in a PKU patient following the ingestion of AA there was an increase in blood glucose. The urinary nitrogen excretion was greater in PKU patients when one compared to three portions of AA mixture was taken. The consumption of the daily requirement of AA mixture in one single does produced increased catabolism in a PKU patient. In conclusion it is recommended that the total daily amount of AA mixture should be divided into a minimum of three portions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828625     DOI: 10.1007/pl00014226

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

1.  Daily rhythms in the concentrations of various amino acids in human plasma.

Authors:  R J Wurtman; C M Rose; C Chou; F F Larin
Journal:  N Engl J Med       Date:  1968-07-25       Impact factor: 91.245

2.  Effect of simultaneous ingestion of L-amino acids and whole protein on plasma amino acid and urea nitrogen concentrations in humans.

Authors:  S S Gropper; P B Acosta
Journal:  JPEN J Parenter Enteral Nutr       Date:  1991 Jan-Feb       Impact factor: 4.016

3.  Plasma amino acid response to ingestion of L-amino acids and whole protein.

Authors:  S S Gropper; D M Gropper; P B Acosta
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-02       Impact factor: 2.839

4.  Dependence of the utilization of a phenylalanine-free amino acid mixture on different amounts of single dose ingested. A case report.

Authors:  M E Herrmann; H G Brösicke; M Keller; E Mönch; H Helge
Journal:  Eur J Pediatr       Date:  1994-07       Impact factor: 3.183

5.  [Phenylalanine-free amino acid mixture: metabolic effects in relation to a single dose].

Authors:  M E Hermann; E Mönch; M Reinbacher; W Kohlen; H G Brösicke
Journal:  Monatsschr Kinderheilkd       Date:  1991-10       Impact factor: 0.323

  5 in total
  15 in total

1.  Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.

Authors:  J Pietz; R Kreis; A Rupp; E Mayatepek; D Rating; C Boesch; H J Bremer
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  Free asymmetric dimethylarginine (ADMA) is low in children and adolescents with classical phenylketonuria (PKU).

Authors:  M Huemer; B Simma; D Mayr; D Möslinger; A Mühl; I Schmid; H Ulmer; O A Bodamer
Journal:  J Inherit Metab Dis       Date:  2012-01-31       Impact factor: 4.982

3.  Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria.

Authors:  Erin L MacLeod; Murray K Clayton; Sandra C van Calcar; Denise M Ney
Journal:  Mol Genet Metab       Date:  2010-04-14       Impact factor: 4.797

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

5.  Chronic kidney disease in adolescent and adult patients with phenylketonuria.

Authors:  Julia B Hennermann; Sylvia Roloff; Jutta Gellermann; Ilka Vollmer; Elke Windt; Barbara Vetter; Ursula Plöckinger; Eberhard Mönch; Uwe Querfeld
Journal:  J Inherit Metab Dis       Date:  2012-11-09       Impact factor: 4.982

6.  Amino Acid Plasma Profiles from a Prolonged-Release Protein Substitute for Phenylketonuria: A Randomized, Single-Dose, Four-Way Crossover Trial in Healthy Volunteers.

Authors:  Mika Scheinin; Anna Barassi; Jouni Junnila; Zsófia Lovró; Giorgio Reiner; Essi Sarkkinen; Anita MacDonald
Journal:  Nutrients       Date:  2020-06-02       Impact factor: 5.717

7.  Dietary intake and nutritional status of patients with phenylketonuria in Taiwan.

Authors:  Hui-Ling Weng; Feng-Jung Yang; Pey-Rong Chen; Wuh-Liang Hwu; Ni-Chung Lee; Yin-Hsiu Chien
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

8.  Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria.

Authors:  Anne Daly; Sharon Evans; Alex Pinto; Richard Jackson; Catherine Ashmore; Júlio César Rocha; Anita MacDonald
Journal:  Nutrients       Date:  2020-08-14       Impact factor: 5.717

9.  Administration of protein substitute and quality of control in phenylketonuria: a randomized study.

Authors:  A MacDonald; G Rylance; P Davies; D Asplin; S K Hall; I W Booth
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

Review 10.  Dietary intervention in the management of phenylketonuria: current perspectives.

Authors:  Júlio César Rocha; Anita MacDonald
Journal:  Pediatric Health Med Ther       Date:  2016-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.